Filing Details
- Accession Number:
- 0001209191-21-050678
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-10 18:23:00
- Reporting Period:
- 2021-08-09
- Accepted Time:
- 2021-08-10 18:23:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
885978 | U S Physical Therapy Inc | USPH | Services-Health Services (8000) | 760364866 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1519948 | D. Graham Reeve | 1300 W Sam Houston Pkwy S Suite 300 Houston TX 77042 | Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-08-09 | 1,559 | $114.15 | 6,936 | No | 4 | S | Indirect | Reeve Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | Reeve Trust |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 14,126 | Direct |
Footnotes
- Includes 14,126 shares which restrictions lapse as to 1,909 shares on October 1, 2021; 1,912 shares on January 1, 2022; 1,433 on each of April 1, July 1 and October 1, 2022; 1,448 shares on January 1, 2023; 788 shares on each of April 1, July 1 and October 1, 2023; 794 shares on January 1, 2024; and 350 shares on each of April 1, July 1 and October 1, 2024 and January 1, 2025, if he is employed by the Company on those dates.
- The price reported is a weighted average price ($114.15). The shares were sold in multiple transactions at prices ranging from $113.96 to $114.42 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.